Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

BSX Insider Trading

BOSTON SCIENTIFIC CORP | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at BOSTON SCIENTIFIC CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2024-10-09 00:48 2024-10-07 Fitzgerald Joseph Michael Officer - EVP & Group Pres, Cardiology OPT+S $85.00 132,527 $11,264,888 160,467 0.0%
2024-10-02 23:22 2024-10-01 Carruthers Wendy Officer - EVP, Human Resources OPT+S $83.86 6,983 $585,594 34,748 0.0%
2024-09-06 23:12 2024-09-05 Mahoney Michael F Director, Officer - Chairman, President & CEO OPT+S $81.17 162,777 $13,212,544 1,622,987 0.0%
2024-09-04 00:29 2024-09-03 Carruthers Wendy Officer - EVP, Human Resources OPT+S $81.70 6,983 $570,511 37,468 0.0%
2024-08-29 23:13 2024-08-28 Fitzgerald Joseph Michael Officer - EVP & Group Pres, Cardiology SELL $80.00 14,132 $1,130,560 176,355 -7.4%
2024-08-26 23:32 2024-08-26 Butcher Arthur C Officer - EVP& Grp Pres, MedSurg & APAC OPT+S $79.25 14,012 $1,110,515 10,802 0.0%
2024-08-02 00:13 2024-08-01 Carruthers Wendy Officer - EVP, Human Resources OPT+S $74.12 6,983 $517,580 40,188 0.0%
2024-07-02 23:13 2024-07-01 Carruthers Wendy Officer - EVP, Human Resources OPT+S $77.30 6,983 $539,786 42,908 0.0%
2024-06-04 00:39 2024-06-03 Carruthers Wendy Officer - EVP, Human Resources OPT+S $75.33 6,983 $526,029 45,628 0.0%
2024-05-30 23:27 2024-05-29 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent OPT+S $75.10 63,802 $4,791,447 28,022 0.0%
2024-05-30 00:04 2024-05-28 Butcher Arthur C Officer - EVP& Grp Pres, MedSurg & APAC OPT+S $75.34 14,011 $1,055,590 20,197 0.0%
2024-05-23 23:12 2024-05-22 Brennan Daniel J. Officer - EVP and CFO OPT+S $75.57 112,075 $8,469,754 223,921 0.0%
2024-05-23 23:11 2024-05-21 Brown Vance R Officer - SVP, GC and Corp. Secretary OPT+S $75.79 33,043 $2,504,240 32,326 0.0%
2024-05-13 23:41 2024-05-10 Thepaut Eric Francis Yves Officer - EVP & Pres, Eur, Mid-East, Afr OPT+S $74.14 12,931 $958,717 31,422 0.0%
2024-05-08 23:11 2024-05-07 Dockendorff Charles J Director SELL $72.70 3,946 $286,874 0 -100.0%
2024-05-02 23:46 2024-05-01 Sorenson John Bradley Officer - EVP, Global Operations OPT+S $71.50 17,587 $1,257,488 50,638 0.0%
2024-05-02 23:42 2024-05-01 Carruthers Wendy Officer - EVP, Human Resources OPT+S $71.47 6,983 $499,075 48,348 0.0%
2024-04-29 23:12 2024-04-26 LUDWIG EDWARD J Director OPT+S $73.29 9,818 $719,562 41,374 0.0%
2024-04-03 01:57 2024-04-01 Sorenson John Bradley Officer - EVP, Global Operations OPT+S $69.30 16,351 $1,133,069 50,638 0.0%
2024-04-03 01:57 2024-04-01 Carruthers Wendy Officer - EVP, Human Resources OPT+S $68.42 6,983 $477,777 51,068 0.0%
2024-03-19 23:41 2024-03-18 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent SELL $66.45 14,506 $963,930 58,098 -20.0%
2024-03-05 02:50 2024-03-01 Carruthers Wendy Officer - EVP, Human Resources OPT+S $66.35 6,983 $463,322 53,788 0.0%
2024-02-28 00:19 2024-02-26 Butcher Arthur C Officer - EVP& Grp Pres, MedSurg & APAC OPT+S $67.07 9,335 $626,098 28,937 0.0%
2024-02-27 00:13 2024-02-23 Carruthers Wendy Officer - EVP, Human Resources OPT+S $66.89 6,983 $467,093 56,508 0.0%
2024-02-23 00:19 2024-02-21 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent SELL $66.35 4,960 $329,096 72,604 -6.4%
2024-02-21 05:03 2024-02-20 Brennan Daniel J. Officer - EVP and CFO OPT+S $65.86 13,662 $899,779 271,542 0.0%
2024-02-15 00:23 2024-02-13 LUDWIG EDWARD J Director OPT+S $65.03 7,000 $455,223 41,374 0.0%
2024-01-17 00:39 2024-01-12 Fitzgerald Joseph Michael Officer - EVP & Group Pres, Cardiology SELL $60.00 11,660 $699,600 173,472 -6.3%
2024-01-11 01:44 2024-01-09 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent OPT+S $59.25 15,172 $898,941 56,588 0.0%
2024-01-06 00:53 2024-01-04 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent OPT+S $58.40 15,000 $876,002 56,588 0.0%
2024-01-05 00:15 2024-01-03 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent SELL $57.82 11,931 $689,862 56,588 -17.4%
2024-01-03 04:30 2023-12-29 Fitzgerald Joseph Michael Officer - EVP & Group Pres, Cardiology OPT+S $57.50 81,940 $4,711,550 174,241 0.0%
2023-12-19 00:11 2023-12-15 Carruthers Wendy Officer - EVP, Human Resources OPT+S $55.61 11,672 $649,075 41,269 0.0%
2023-12-08 00:10 2023-12-06 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent SELL $55.03 353 $19,426 56,588 -0.6%
2023-11-22 00:15 2023-11-20 Butcher Arthur C Officer - EVP& Grp Pres, MedSurg & APAC OPT+S $54.06 8,278 $447,509 6,977 0.0%
2023-11-17 00:16 2023-11-15 Carruthers Wendy Officer - EVP, Human Resources OPT+S $54.17 11,671 $632,269 46,532 0.0%
2023-11-08 00:11 2023-11-06 Mahoney Michael F Director, Officer - Chairman, President & CEO OPT+S $52.51 113,356 $5,951,983 1,498,922 0.0%
2023-10-17 23:12 2023-10-16 Carruthers Wendy Officer - EVP, Human Resources OPT+S $49.79 11,671 $581,063 51,795 0.0%
2023-10-11 01:11 2023-10-09 Mahoney Michael F Director, Officer - Chairman, President & CEO OPT+S $52.09 113,355 $5,904,481 1,498,922 0.0%
2023-09-21 23:09 2023-09-20 Fitzgerald Joseph Michael Officer - EVP & Group Pres, Cardiology SELL $55.00 15,867 $872,685 197,992 -7.4%
2023-09-16 01:34 2023-09-15 Carruthers Wendy Officer - EVP, Human Resources OPT+S $53.95 11,671 $629,694 57,058 0.0%
2023-09-13 00:37 2023-09-12 Mahoney Michael F Director, Officer - Chairman, President & CEO OPT+S $53.91 113,355 $6,110,447 1,498,922 0.0%
2023-08-30 23:10 2023-08-28 Mirviss Jeffrey B. Officer - EVP&Pres, Periph Intervent SELL $53.48 18,628 $996,229 60,588 -23.5%
2023-08-28 23:18 2023-08-25 Brown Vance R Officer - SVP, GC and Corp. Secretary SELL $50.52 15,750 $795,756 28,578 -35.5%
2023-08-23 00:09 2023-08-21 Butcher Arthur C Officer - EVP& Grp Pres, MedSurg & APAC SELL $50.40 6,600 $332,661 11,396 -36.7%
2023-08-18 23:10 2023-08-18 Dockendorff Charles J Director SELL $50.74 17,079 $866,631 3,946 -81.2%
2023-08-15 23:16 2023-08-15 Carruthers Wendy Officer - EVP, Human Resources OPT+S $51.30 11,671 $598,678 62,321 0.0%
2023-07-19 00:44 2023-07-17 Carruthers Wendy Officer - EVP, Human Resources OPT+S $52.85 11,671 $616,774 67,584 0.0%
2023-06-22 23:19 2023-06-21 Butcher Arthur C Officer - EVP& Grp Pres, MedSurg & APAC SELL $53.80 6,697 $360,298 17,453 -27.7%
2023-06-15 23:53 2023-06-15 Carruthers Wendy Officer - EVP, Human Resources OPT+S $53.24 11,671 $621,359 72,847 0.0%
SHOW ENTRIES
51-100 OF 1,038

How to Interpret $BSX Trades

Not every insider transaction in BOSTON SCIENTIFIC CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $BSX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for BSX

Insider activity data for BOSTON SCIENTIFIC CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $BSX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.